title: Finding Ms or Mr Right: Which miRNA to target in AF?
authors.affiliation: Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany.
authors.forename: Cristina E
authors.initials: CE
authors.lastname: Molina
authors.affiliation: Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany. Electronic address: niels.voigt@med.uni-goettingen.de.
authors.forename: Niels
authors.initials: N
authors.lastname: Voigt
mesh_terms: D001281:Atrial Fibrillation / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000627:therapeutic use; D034622:RNA Interference; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics; D059467:Transcriptome; D020257:Ventricular Remodeling / Q000235:genetics
chemical_list: C550906:MIRN208 microRNA, human; D035683:MicroRNAs; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases